| S0285 |
Bay 41-4109 racemate
|
BAY 41-4109 racemate (BAY41-4109 Racemic) is a mixture of R-isomer of BAY 41-4109 and S-isomer of BAY 41-4109. BAY 41-4109 an antiviral compound that inhibits human hepatitis B virus (HBV) with IC50 of 53 nM.
|
-
Nat Commun, 2021, 12(1):2114
|
|
| S4199 |
Antazoline HCl
|
Antazoline hydrochloride(Phenazoline hydrochloride) is a first-generation antihistamine with anticholinergic properties and is commonly used to relieve nasal congestion and in eye drops. Antazoline hydrochloride exhibits a significant inhibitory effect on HBV DNA in the Huh7 cells, with an EC50 of 2.349 μmol/L.
|
|
|
| S0038 |
AB-423
|
AB-423, a member of the sulfamoylbenzamide (SBA) class of hepatitis B virus (HBV) capsid inhibitors, shows potent inhibition of HBV replication with EC50 of 0.08 μM - 0.27 μM and EC90 of 0.33 μM - 1.32 μM in cells. Phase 1.
|
|
|
| E3309 |
Polygala Fallax Hemsl. Rhizome Extract
|
Polygala Fallax Hemsl. Rhizome Extract is drawed from the rhizome of Polygala Fallax Hemsl., which has effects on immune function, such as anti-stress, anti-inflammatory, blood activating, lipid regulating, and in vitro inhibition of hepatitis B virus.
|
|
|
| S0796 |
JNJ-632
|
JNJ-632 is a potent hepatitis B virus (HBV) capsid assembly modulator (CAM) with mean EC50 of 121 nM in HepG2.2.15 cells.
|
|
|
| E0094 |
Morphothiadin
|
Morphothiadin (GLS4) is a potent inhibitor on the replication of both wild-type and adefovir-resistant Hepatitis B virus (HBV) with an IC50 of 12 nM. This compound, a nucleoside analogs that target the virus polymerase, can block the HBV replication cycle and HBV-associated chronic liver diseases.
|
-
Viruses, 2024, 16(3)323
|
|
| S6729 |
Besifovir
|
Besifovir is novel and potent acyclic nucleotide phosphonate used to treat hepatitis B virus (HBV) infection.
|
|
|
| S6453 |
Bicyclol
|
Bicyclol (SY-801) is a drug that can improve liver function and inhibit HBV replication.
|
|
|
| S8627 |
OSS_128167
|
OSS_128167 (SIRT6-IN-1) is a specific SIRT6 inhibitor with IC50 values of 89, 1578 and 751 μM for SIRT6, SIRT1 and SIRT2, respectively. This compound has anti-viral effect in HBV transcription and replication.
|
-
Front Immunol, 2024, 15:1402834
-
Sci Rep, 2024, 14(1):30924
-
Antioxidants (Basel), 2023, 12(3)714
|
|
| S1704 |
Emtricitabine (FTC)
|
Emtricitabine (FTC) is a new nucleoside agent that has activity against both human immunodeficiency virus (HIV) and hepatitis B virus. It is a reverse transcriptase inhibitor, and its intracellular half-life is 39 h.
|
-
Cancer Discov, 2025, 10.1158/2159-8290.CD-24-1317
-
HIV Med, 2025, 26(2):285-294
-
Immunity, 2024, 57(12):2928-2944.e6
|
|